PGI19 Costs and Effects of Dual Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C in Germany

Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.768
https://www.valueinhealthjournal.com/article/S1098-3015(12)02481-3/fulltext
Section Title : Gastrointestinal Disorders
Section Order : 280
First Page : A329
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02481-3&doi=10.1016/j.jval.2012.08.768
HEOR Topics :
Tags :
Regions :